Search results for "FDA update"


 
Results 21 - 30 of about 76 for "FDA update".

FDA update

systems. Certain models of the MiniMed insulin pump were recalled by Medtronic due to potential cybersecurity risks, the FDA warned on June 27. ... Because the manufacturer cannot update the MiniMed 508 and MiniMed Paradigm series insulin pump models,
July 2019

FDA update

The FDA in January approved an expanded indication for the Integra Omnigraft Dermal Regeneration Matrix to treat certain diabetic foot ulcers that last longer than 6 weeks.
February 2016

FDA update

A once-daily combination pill of dapagliflozin and metformin HCl extended-release (Xigduo XR) was recently approved by the FDA. ... It is the first once-daily combination of a sodium-glucose cotransporter 2 inhibitor and metformin to be approved by the
November 2014

FDA update

1 FDA press release announced. Insulet Corporation issued the notification because the failures or delays have resulted in 66 medical device reports, including 3 that required medical intervention. ... The FDA recommends that consumers using products
December 2015

FDA update

Empagliflozin (Jardiance) is approved for a new indication—to reduce the risk of cardiovascular death in adults with type 2 diabetes and cardiovascular disease, the FDA announced on Dec. ... The most common side effects are urinary tract infections and
December 2016

FDA update

The benefits of the angiotensin-receptor blocker olmesartan (Benicar, Benicar HCT, Azor, Tribenzor) continue to outweigh the risks for diabetic patients, according to a recently concluded FDA safety review. ... Overall, the FDA determined that the
July 2014

FDA update

https://diabetes.acponline.org/archives/2017/12/08/7.htm. Two lots of metformin hydrochloride oral solution (Riomet), 500 mg/5 mL, were recalled due to fungal contamination, the FDA said. ... Sun Pharmaceutical Industries, Inc., has recalled two lots of
December 2017

FDA update

The FDA recently approved a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized. ... This is the first glucose meter cleared by the FDA for use in these patients.
November 2014

FDA update

announced. Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently announced. ... Aflibercept was previously approved to treat wet age-related macular
April 2015

FDA update

The Abbott FreeStyle Insulinx blood glucose meters were recently recalled because at extremely high blood glucose levels of 1,024 mg/dL and above, the meters will display and store in memory an incorrect test result that is 1,024 mg/dL below the
July 2013

Result Page: Prev   1   2   3   4   5   6   7   8   Next